BSYI (Biosyntech) Cyclically Adjusted FCF per Share: $0.00 (As of Dec. 2009)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biosyntech Cyclically Adjusted FCF per Share?

Biosyntech BSYI Cyclically Adjusted FCF per Share is $0.00 as of Dec. 2009.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Biosyntech's adjusted free cash flow per share for the three months ended in Dec. 2009 was $-0.014. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.00 for the trailing ten years ended in Dec. 2009.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-27), Biosyntech's current stock price is $1.0E-5. Biosyntech's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2009 was $0.00. Biosyntech's Cyclically Adjusted Price-to-FCF of today is .


Biosyntech  (OTCPK:BSYI) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Biosyntech Cyclically Adjusted FCF per Share Related Terms


Biosyntech Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Biosyntech's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosyntech Cyclically Adjusted FCF per Share Chart

Biosyntech Annual Data
Trend Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biosyntech Quarterly Data
Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BSYI vs NSPX, HSTC, PZRXQ: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Biosyntech's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyntech Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosyntech's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Biosyntech's Cyclically Adjusted Price-to-FCF falls into.



Biosyntech Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biosyntech's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2009 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2009 (Change)*Current CPI (Dec. 2009)
=-0.014/90.7032*90.7032
=-0.014

Current CPI (Dec. 2009) = 90.7032.

Biosyntech Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200003 0.000 74.901 0.000
200006 -0.037 75.454 -0.044
200009 -0.021 75.928 -0.025
200012 -0.039 76.402 -0.046
200103 -0.028 76.719 -0.033
200106 -0.043 77.983 -0.050
200109 0.018 77.904 0.021
200112 -0.061 76.956 -0.072
200203 -0.015 78.141 -0.017
200206 -0.018 78.931 -0.021
200209 -0.022 79.721 -0.025
200212 0.025 79.879 0.028
200303 -0.522 81.459 -0.581
200306 -0.014 80.985 -0.016
200309 -0.018 81.459 -0.020
200312 0.023 81.538 0.026
200403 -0.046 82.091 -0.051
200406 -0.020 83.039 -0.022
200409 -0.020 82.960 -0.022
200412 0.025 83.276 0.027
200503 -0.070 83.987 -0.076
200506 -0.022 84.461 -0.024
200509 -0.032 85.647 -0.034
200512 -0.024 85.015 -0.026
200603 -0.053 85.805 -0.056
200606 -0.017 86.516 -0.018
200609 -0.015 86.279 -0.016
200612 -0.021 86.437 -0.022
200703 -0.019 87.780 -0.020
200706 -0.023 88.412 -0.024
200709 -0.021 88.412 -0.022
200712 -0.017 88.491 -0.017
200803 -0.026 88.965 -0.027
200806 -0.019 91.177 -0.019
200809 -0.027 91.414 -0.027
200812 -0.024 89.518 -0.024
200903 -0.019 90.071 -0.019
200906 -0.017 90.940 -0.017
200909 -0.018 90.624 -0.018
200912 -0.014 90.703 -0.014

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.00 mean?
Biosyntech (BSYI) has a Cyclically Adjusted FCF per Share of $0.00 as of Dec. 2009. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Biosyntech and its competitors.
Is Biosyntech's Cyclically Adjusted FCF per Share too high?
Biosyntech's current Cyclically Adjusted FCF per Share is $0.00.
How does Biosyntech's Cyclically Adjusted FCF per Share compare to NSPX and HSTC?
Biosyntech's Cyclically Adjusted FCF per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Biosyntech and its competitors. Biosyntech's current Cyclically Adjusted FCF per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosyntech stock overvalued right now?
Biosyntech (BSYI) has a current Cyclically Adjusted FCF per Share of $0.00. The current Cyclically Adjusted FCF per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Biosyntech (BSYI), the current Cyclically Adjusted FCF per Share is $0.00 as of Dec. 2009. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosyntech Business Description

Address 475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3
Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.